Skip to main content

Advertisement

Log in

The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?

Cellular and Molecular Life Sciences Aims and scope Submit manuscript

Abstract.

After more than 40 years of clinical use, the mechanisms of action of valproate in epilepsy, bipolar disorder and migraine are still not fully understood. However, recent findings reviewed here shed new light on the cellular effects of valproate. Beyond the enhancement of γ-aminobutyric acid-mediated neurotransmission, valproate has been found to affect signalling systems like the Wnt/β-catenin and ERK pathways and to interfere with inositol and arachidonate metabolism. Nevertheless, the clinical relevance of these effects is not always clear. Valproate treatment also produces marked alterations in the expression of multiple genes, many of which are involved in transcription regulation, cell survival, ion homeostasis, cytoskeletal modifications and signal transduction. These alterations may well be relevant to the therapeutic effects of valproate, and result from its enhancement of activator protein-1 DNA binding and direct inhibition of histone deacetylases, and possibly additional, yet unknown, mechanism(s). Most likely, both immediate biochemical and longer-term genomic influences underlie the effects of valproate in all three indications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. Rosenberg.

Additional information

Received 14 February 2007; received after revision 26 March 2007; accepted 25 April 2007

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosenberg, G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?. Cell. Mol. Life Sci. 64, 2090–2103 (2007). https://doi.org/10.1007/s00018-007-7079-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-007-7079-x

Keywords.

Navigation